Literature DB >> 19592271

Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review.

Katy Gallop1, Diane Wild, Annabel Nixon, Lara Verdian, Joyce A Cramer.   

Abstract

The aim of this study was to conduct a review of the literature to evaluate the impact of LGS on the HRQL of children with LGS and their caregivers. The literature search revealed that there is limited published research on the impact of LGS on the HRQL of the child or caregiver. LGS has a major physical impact on a child, with a high frequency of seizures, and a high rate of seizure-related injuries. It interferes with all aspects of the child's intellectual and social development. The patient, and also his/her entire family are affected. Caring for a child with LGS is described as a 'burden', with increased anxiety about injury from seizures as well as the strain associated with providing continuous care. Overall, there is a lack of research on LGS, specifically the extent of the impact of LGS on the HRQL of the child and caregiver is under-explored.

Entities:  

Mesh:

Year:  2009        PMID: 19592271     DOI: 10.1016/j.seizure.2009.06.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  10 in total

Review 1.  Clobazam : in patients with Lennox-Gastaut syndrome.

Authors:  Lily P H Yang; Lesley J Scott
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

2.  Efficacy and safety of rufinamide in pediatric epilepsy.

Authors:  David T Hsieh; Elizabeth A Thiele
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

3.  Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.

Authors:  Joshua S Kaplan; Nephi Stella; William A Catterall; Ruth E Westenbroek
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

4.  Lennox-Gastaut syndrome: impact on the caregivers and families of patients.

Authors:  Patricia A Gibson
Journal:  J Multidiscip Healthc       Date:  2014-10-04

5.  Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome.

Authors:  Clément François; John M Stern; Augustina Ogbonnaya; Tasneem Lokhandwala; Pamela Landsman-Blumberg; Amy Duhig; Vivienne Shen; Robin Tan
Journal:  J Mark Access Health Policy       Date:  2017-05-19

Review 6.  Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.

Authors:  Adam Strzelczyk; Susanne Schubert-Bast
Journal:  CNS Drugs       Date:  2021-01-21       Impact factor: 5.749

7.  Caregiver burden in epilepsy: determinants and impact.

Authors:  Ioannis Karakis; Andrew J Cole; Georgia D Montouris; Marta San Luciano; Kimford J Meador; Charitomeni Piperidou
Journal:  Epilepsy Res Treat       Date:  2014-04-08

8.  Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE.

Authors:  Mike Kerr; Christine Linehan; Christian Brandt; Kousuke Kanemoto; Jun Kawasaki; Kenji Sugai; Yukari Tadokoro; Vicente Villanueva; Jo Wilmshurst; Sarah Wilson
Journal:  Epilepsia Open       Date:  2016-09-15

9.  Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families.

Authors:  Jennifer S Jeffrey; Janet Leathem; Chontelle King; Heather C Mefford; Kirsty Ross; Lynette G Sadleir
Journal:  Epilepsia Open       Date:  2021-01-19

10.  Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex.

Authors:  Siu Hing Lo; Jade Marshall; Hanna Skrobanski; Andrew Lloyd
Journal:  Pharmacoecon Open       Date:  2021-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.